TreeFrog Therapeutics
Created in 2018
Up & running (A)
Existing signals show a regular activitySocial networks
913 21,422Global tags
Activities
Technologies
Entity types
Location
30 Av. Gustave Eiffel Bat A, 33600 Pessac, France
Pessac
France
Employees
Scale: 51-200
Estimated: 177
SIREN
343619102Engaged catalyst
51
0 0Added in Motherbase
5 years, 6 months ago
Value proposition
Cell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture, and bioreactor stem cell cultivationOriginal language
Cell Therapy for All
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.
TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.
Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
TreeFrog Therapeutics I iPS-derived Cell Therapies I Cell Therapy for All
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.
https://treefrog.fr/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 | MOVE: Mobility Re-imagined | Other 14 Nov 2024 | | |
 Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 12 Apr 2025 | | |
 | Réseau SATT | Other 8 Oct 2024 | | |
 Apec Grand Est Human ressources, Human Resources Services | Apec Grand Est Human ressources, Human Resources Services | Other 4 Oct 2024 | | |
 Start Industrie Non-profit Organizations | Start Industrie Non-profit Organizations | Other 22 May 2024 | | |
 SAYENS Research, Startup accelerator & VC, Research Services | SAYENS Research, Startup accelerator & VC, Research Services | Other 11 May 2024 | | |
 Ministry of Economy Government Administration | Ministry of Economy Government Administration | Other 12 Feb 2024 | | |
 | SATT Aquitaine Science Transfert | Other 8 Oct 2024 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 14 Dec 2023 | | |
 ALPHA-RLH Research, Public business cluster, French Cluster, Research Services | ALPHA-RLH Research, Public business cluster, French Cluster, Research Services | Other 4 Dec 2023 | | |